Unknown

Dataset Information

0

Structural basis for the unfolding of anthrax lethal factor by protective antigen oligomers.

ABSTRACT: The protein transporter anthrax lethal toxin is composed of protective antigen (PA), a transmembrane translocase, and lethal factor (LF), a cytotoxic enzyme. After its assembly into holotoxin complexes, PA forms an oligomeric channel that unfolds LF and translocates it into the host cell. We report the crystal structure of the core of a lethal toxin complex to 3.1-Å resolution; the structure contains a PA octamer bound to four LF PA-binding domains (LF(N)). The first ?-helix and ?-strand of each LF(N) unfold and dock into a deep amphipathic cleft on the surface of the PA octamer, which we call the ? clamp. The ? clamp possesses nonspecific polypeptide binding activity and is functionally relevant to efficient holotoxin assembly, PA octamer formation, and LF unfolding and translocation. This structure provides insight into the mechanism of translocation-coupled protein unfolding.

SUBMITTER: Feld GK 

PROVIDER: S-EPMC3133606 | biostudies-literature | 2010 Nov

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Structural basis for the unfolding of anthrax lethal factor by protective antigen oligomers.

Feld Geoffrey K GK   Thoren Katie L KL   Kintzer Alexander F AF   Sterling Harry J HJ   Tang Iok I II   Greenberg Shoshana G SG   Williams Evan R ER   Krantz Bryan A BA  

Nature structural & molecular biology 20101031 11

The protein transporter anthrax lethal toxin is composed of protective antigen (PA), a transmembrane translocase, and lethal factor (LF), a cytotoxic enzyme. After its assembly into holotoxin complexes, PA forms an oligomeric channel that unfolds LF and translocates it into the host cell. We report the crystal structure of the core of a lethal toxin complex to 3.1-Å resolution; the structure contains a PA octamer bound to four LF PA-binding domains (LF(N)). The first α-helix and β-strand of each  ...[more]

Similar Datasets

Unknown Lethal factor of anthrax toxin binds monomeric form of protective antigen.
| S-EPMC1986636 | biostudies-literature
Unknown Interactions of anthrax lethal factor with protective antigen defined by site-directed spin labeling.
| S-EPMC3033316 | biostudies-literature
Unknown Lethal factor and anti-protective antigen IgG levels associated with inhalation anthrax, Minnesota, USA.
| S-EPMC3901492 | biostudies-literature
Unknown Asymmetric Cryo-EM Structure of Anthrax Toxin Protective Antigen Pore with Lethal Factor N-Terminal Domain.
| S-EPMC5666345 | biostudies-literature
Unknown Plant-based vaccine: mice immunized with chloroplast-derived anthrax protective antigen survive anthrax lethal toxin challenge.
| S-EPMC1307059 | biostudies-literature
Unknown Lethal factor unfolding is the most force-dependent step of anthrax toxin translocation.
| S-EPMC2779827 | biostudies-literature
Unknown Anthrax toxin translocation complex reveals insight into the lethal factor unfolding and refolding mechanism.
| S-EPMC8219829 | biostudies-literature
Unknown Anthrax protective antigen delivered by Salmonella enterica serovar Typhi Ty21a protects mice from a lethal anthrax spore challenge.
| S-EPMC2663156 | biostudies-literature
Unknown Anthrax lethal factor inhibition.
| S-EPMC1138260 | biostudies-literature
Unknown Select human anthrax protective antigen epitope-specific antibodies provide protection from lethal toxin challenge.
| S-EPMC2891133 | biostudies-literature